Repeatability of Positron Emission Tomography (TEP) With fluorométhyl-(18F)-diméthyl-2-hydroxyéthyl-ammonium

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03105869

Enrollment

Registered

2017-04-10

Start date

2014-12-16

Completion date

2016-12-31

Last updated

2017-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Keywords

repeatability, positron emission tomography (PET), fluorocholine

Brief summary

Monocentric study. Objective : Determination of the repeatability of fluorocholine PET/CT in prostate cancer

Detailed description

A second PET/CT with fluorocholine is performed within 2 weeks after a first examination performed in patient referred for an initial prostate cancer or a biological suspicion of relapse.

Interventions

DIAGNOSTIC_TESTfluorocholine PET/CT

standard diagnostic PET/CT procedure

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

DIAGNOSTIC

Masking

NONE

Intervention model description

test and retest in a single group of patient

Eligibility

Sex/Gender

MALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

: * biological suspicion of relapse of prostate cancer or initial staging of prostate cancer * positive PET/CT with fluororocholine

Exclusion criteria

: -none

Design outcomes

Primary

Measure	Time frame	Description
reproducibility of the results	2 weeks	Comparison of the number and location of identified lesions and comparison of lesion uptake

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026